Legend Biotech Corporation
(LEGN - NASDAQ)
23,86 USD
📋 Profilo Aziendale

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally.

|